Skip to content

pharmaceuticals.co.nz

Drugs, medicines and medical news
Main navigation

Category: respiratory diseases

Chiesi and Gossamer collaborate to develop drug to treat respiratory diseases

Gossamer’s seralutinib is designed to treat pulmonary arterial hypertension and other indications

May 8, 2024 Chiesi Group, Gossamer Bio, News, Pulmonary Arterial Hypertension, pulmonary hypertension associated with interstitial lung disease, respiratory diseases, seralutinib

ALTURiX acquires exclusive UK rights to three new products

The new products are in the areas of gastrointestinal and respiratory medicines

February 7, 2024 ALTURiX, gastrointestinal diseases, News, respiratory diseases
Proudly powered by WordPress | Theme: Hive Lite by Pixelgrade.
Footer navigation
  • Privacy Policy